Neck PainNCT06572579
A Pilot Registry for Ultrasound-guided Pharmacopuncture
An observational study of Neck Pain and Back Pain, run by Jaseng Medical Foundation at 3 sites in South Korea.
Trial summary
A pilot study of prospective resigstry to evaluate the safety and efficacy of ultrasound-guided pharmacopuncture for spinal disorders Read more about this study
- Who is it for?
- Ages 19 to 70 years
- What is being tested?
- Ultrasound-guided pharmacopuncture treatment
- Type of treatment
- Surgery or procedure
- How many people
- 50 participants
- Where
- 3 sitesSouth Korea
- Study dates
- 23 Sep 2024to 7 Feb 2025
- How long will I take part?
- 12 Weeks
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients diagnosed with spinal disorders who have undergone ultrasound-guided pharmacopuncture treatment
Who may be able to join
- Individuals diagnosed with spinal disorders (M code and S code based on KCD criteria)
- Outpatients scheduled for ultrasound-guided pharmacopuncture treatment
- Individuals aged 19 years or older and under 70 years
- Individuals who agree to participate in the clinical study and voluntarily sign the consent form
Who cannot join
- Individuals who are unable to complete the consent form
- Individuals who are deemed unsuitable for participation in the clinical study by the researcher
Trial locations and contacts
3 sites in 1 country.
South Korea3 sites
Bucheon Jaseng Hospital of Korean Medicine
Bucheon-si, Gyeonggi Province, 14598
Daejeon Jaseng Hospital of Korean medicine
Daejeon, Seo-gu
Jaseng Hospital of Korean medicine
Seoul, Gangnam-Gu, 135-896
About this study
Official title: Safety and Effectiveness of Ultrasound-guided Pharmacopuncture for Spinal Diseases: A Pilot Registry
A pilot study of prospective resigstry to evaluate the safety and efficacy of ultrasound-guided pharmacopuncture for spinal disorders
Read the detailed description
This study aims to evaluate the safety and efficacy of ultrasound-guided pharmacopuncture by collecting information on adverse reactions, efficacy assessment variables, and treatment methods from patients diagnosed with spinal disorders who have undergone ultrasound-guided pharmacopuncture treatment.
- Being tested
- Ultrasound-guided pharmacopuncture treatment
- Medical subject headings
- Neck Pain, Back Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Ultrasound-guided pharmacopuncture treatmentProcedure or surgery
Pharmacopuncture treatment using ultrasound-guidance
| Study group | Role | What they receive |
|---|---|---|
| Ultrasound-guided pharmacopuncture group | Patients diagnosed with spinal disorders who have undergone ultrasound-guided pharmacopuncture treatment Receives: Procedure: Ultrasound-guided pharmacopuncture treatment |
What is being measured
The primary outcome is the main question the study is designed to answer.
Adverse Event
Adverse events assessment
Measured: Treatment visits up to 12 weeks, and Week 2, 4, 8, 12 follow-ups
Secondary outcomes (4)
Spinal pain numeric rating scale
Spinal pain numeric rating scale
Measured: Week 0, Treatment visits up to 12 weeks, and Week 2, 4, 8, 12 follow-ups
Disability index
Neck disability index or Oswestry Disability Index
Measured: Week 0, 2, 4, 8, 12
EQ-5D-5L
Quality of life using EQ-5D-5L
Measured: Week 0, 2, 4, 8, 12
Patient satisfaction
Patient satisfaction survey
Measured: Week 4
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Aug 2024
- Study start23 Sep 2024
- Primary completion15 Oct 2024
- Study completion7 Feb 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Neck PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 50 participants (actual)
- Target duration
- 12 Weeks
Sponsor and investigators
- Lead sponsor
- Jaseng Medical Foundation
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- In-Hyuk Ha, Dr, Study director, Jaseng Medical Foundation
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06572579
- Sponsor's protocol ID
- JS-CT-2024-04
- Status last verified
- Sep 2024
- First submitted
- 22 Jul 2024
- Last updated
- 2 Oct 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 2 Oct 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Safety and Effectiveness of Ultrasound-guided Pharmacopuncture for Spinal Diseases: A Pilot Registry
- ClinicalTrials.gov ID
- NCT06572579
- Acronym / sponsor ID
- JS-CT-2024-04
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- Jaseng Medical FoundationUniversity, hospital or other
- Study start
- 23 Sep 2024 (actual)
- Primary completion
- 15 Oct 2024 (actual)
- Study completion
- 7 Feb 2025 (actual)
- First posted
- 27 Aug 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A pilot study of prospective resigstry to evaluate the safety and efficacy of ultrasound-guided pharmacopuncture for spinal disorders
Detailed description
This study aims to evaluate the safety and efficacy of ultrasound-guided pharmacopuncture by collecting information on adverse reactions, efficacy assessment variables, and treatment methods from patients diagnosed with spinal disorders who have undergone ultrasound-guided pharmacopuncture treatment.
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Target follow-up
- 12 Weeks
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Ultrasound-guided pharmacopuncture group | – | Procedure: Ultrasound-guided pharmacopuncture treatmentPatients diagnosed with spinal disorders who have undergone ultrasound-guided pharmacopuncture treatment |
Who may qualify
- Ages
- 19 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients diagnosed with spinal disorders who have undergone ultrasound-guided pharmacopuncture treatment
Key inclusion criteria (4 listed)
- Individuals diagnosed with spinal disorders (M code and S code based on KCD criteria)
- Outpatients scheduled for ultrasound-guided pharmacopuncture treatment
- Individuals aged 19 years or older and under 70 years
- Individuals who agree to participate in the clinical study and voluntarily sign the consent form
Key exclusion criteria (2 listed)
- Individuals who are unable to complete the consent form
- Individuals who are deemed unsuitable for participation in the clinical study by the researcher
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Ultrasound-guided pharmacopuncture treatmentPharmacopuncture treatment using ultrasound-guidance | Procedure or surgery | Ultrasound-guided pharmacopuncture group |
Primary outcome
Adverse Event
Time frame: Treatment visits up to 12 weeks, and Week 2, 4, 8, 12 follow-ups
Adverse events assessment
4 secondary outcomes
Spinal pain numeric rating scale
Time frame: Week 0, Treatment visits up to 12 weeks, and Week 2, 4, 8, 12 follow-ups
Disability index
Time frame: Week 0, 2, 4, 8, 12
EQ-5D-5L
Time frame: Week 0, 2, 4, 8, 12
Patient satisfaction
Time frame: Week 4
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Oct 2025.
- Individual participant dataSharing planned: No
Related trials for Neck Pain
Not yet recruiting
Effects of Whole-Body Vibration and Cervical Stabilization With Core Stabilization in Young Adults With Non-Specific Low Back Pain
Nonspecific Low Back Pain
Recruiting
Strain Counter Strain and Conventional Stretching in School-aged Children With Mechanical Neck Pain Due to Prolong Screen Use
Mechanical Neck Pain
Recruiting
Effects of Alexander Technique Versus Feldenkrais Somatic Training in Patients With Text Neck Syndrome
Text Neck Syndrome
Recruiting
Longitudinal Stripping Massage vs. Percussion Device for Neck Pain: Ultrasound Study.
Chronic Neck Pain
RecruitingPhase 2
Effectiveness of Phenotype-based Pain Management Guidelines for Head and Neck Cancer Related Pain: a Pilot Study
Cancer Pain, Orofacial Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
In-Hyuk Ha, Dr study director
Jaseng Medical Foundation
3 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Neck Pain and Back Pain, run by Jaseng Medical Foundation at 3 sites in South Korea.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Adverse Event (time frame: Treatment visits up to 12 weeks, and Week 2, 4, 8, 12 follow-ups). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2025.